WuXi Biologics - Total Other Finance Cost

WuXi Biologics's Fiscal Year is From January To December - All Figures are in CNY, Billions.

The item "Total-Other-Finance-Cost" stands at -1.20 Billion Chinese Yuans for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 03/31/2015, the period currently displayed.

WuXi Biologics's second quarter result of -0.6507 Billion CNY for the item "Total Other Finance Cost" represents a decrease of -209.64 percent compared to it's first quarter result.

Also, WuXi Biologics's second quarter result of -0.6507 Billion CNY for the item "Total Other Finance Cost" represents a decrease of -1,100.40 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), WuXi Biologics's second quarter result of -1.20 Billion CNY for the item "Total Other Finance Cost" represents a decrease of -99.53 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.8331 Billion Chinese Yuans compared to the value the year prior.
The 1 year change is -0.8331 Billion Chinese Yuans.
The 3 year change is -0.6676 Billion Chinese Yuans.
The 5 year change is -0.9331 Billion Chinese Yuans.
The 10 year change is -1.19 Billion Chinese Yuans.

The Serie's long term average value is -0.234 Billion Chinese Yuans. It's latest available value, on 06/30/2025, is -0.962 Billion Chinese Yuans lower, compared to it's long term average value.
The Serie's change in Chinese Yuans from it's minimum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is +0.0 Billion.
The Serie's change in Chinese Yuans from it's maximum value, on 09/30/2015, to it's latest available value, on 06/30/2025, is -1.19 Billion.